featured
Ultra-Hypofractionated Proton Radiotherapy for Low- and Intermediate-Risk Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer: 5-Year Outcomes.
Int. J. Radiat. Oncol. Biol. Phys 2021 Feb 12;[EPub Ahead of Print], J Kubeš, A Haas, V Vondráček, M Andrlík, M Navrátil, S Sláviková, P Vítek, K Dědečková, J Prausová, B Ondrová, Š Vinakurau, A Grebenyuk, T Doležal, B Velacková, J RosinaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.